Cargando…
Systems Pharmacology-Based Precision Therapy and Drug Combination Discovery for Breast Cancer
SIMPLE SUMMARY: Breast cancer (BC) is a typical global cancer and the second leading cause of cancer-related deaths among women worldwide. BC is a heterogeneous disease with several subtypes, and it is a challenge to use multi-omic data effectively to find suitable drugs for patients. In this paper,...
Autores principales: | Cui, Ze-Jia, Gao, Min, Quan, Yuan, Lv, Bo-Min, Tong, Xin-Yu, Dai, Teng-Fei, Zhou, Xiong-Hui, Zhang, Hong-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305788/ https://www.ncbi.nlm.nih.gov/pubmed/34298802 http://dx.doi.org/10.3390/cancers13143586 |
Ejemplares similares
-
Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine
por: Tan, Linyun, et al.
Publicado: (2023) -
Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge
por: Xu, Xuan, et al.
Publicado: (2021) -
Systems Chemical Genetics-Based Drug Discovery: Prioritizing Agents Targeting Multiple/Reliable Disease-Associated Genes as Drug Candidates
por: Quan, Yuan, et al.
Publicado: (2019) -
PheWAS-Based Systems Genetics Methods for Anti-Breast Cancer Drug Discovery
por: Gao, Min, et al.
Publicado: (2019) -
Toxins in Drug Discovery and Pharmacology
por: Peigneur, Steve, et al.
Publicado: (2018)